Business
Werewolf Therapeutics to Participate in Upcoming Investor Conferences
WATERTOWN, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune-mediated conditions, today announced that management will participate in the following upcoming investor conferences in the month of May: The Citizens Life Sciences Conferenc
About this update from Werewolf Therapeutics, Inc.
[{"type":"image","alt":"Werewolf Therapeutics, Inc.","displaySize":"","headline":null,"caption":"Werewolf Therapeutics, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":158,"url":"https://media.zenfs.com/en/globenewswire.com/3a0b348d8361243b3fb2ff9099161d3c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/C6Y97KmUdGS6XpzuliXDig--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyMTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/3a0b348d8361243b3fb2ff9099161d3c","width":300,"height":158}},"lazy":false},{"type":"text","content":"WATERTOWN, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune-mediated conditions, today announced that management will participate in the following upcoming investor conferences in the month of May:","length":463,"tagName":"p"},{"type":"text","content":"The Citizens Life Sciences Conference 2025Date: Thursday, May 8, 2025 Time: 10:00am ETLocation: New York Hilton Midtown Management will participate in a fireside chat","length":170,"tagName":"p"},{"type":"text","content":"Bank of America Securities 2025 Health Care ConferenceDate: Wednesday, May 14, 2025 Time: 3:15pm PTLocation: The Encore Hotel, Las Vegas, NVManagement will participate in a fireside chat","length":190,"tagName":"p"},{"type":"text","content":"Live webcast links for the fireside chats will be available at https://investors.werewolftx.com/news-and-events/events. Archived replays will be available for approximately 90 days following the respective conferences.","length":223,"tagName":"p"},{"type":"text","content":"About Werewolf Therapeutics:","length":28,"tagName":"p"},{"type":"text","content":"Werewolf Therapeutics, Inc., is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune-mediated conditions. The Company is leveraging its proprietary PREDATOR® platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. W...